Chart calendar Dermapharm Holding SE

9c735c29217d0869ae0a2d62fb52.m71KUGySyTXYsEy9kKzcf4Mb_6x46m28qQRBaS4Mhdc.qPMZHxb0qnOzwzTI1v--J8g2ipsUrluJ40UvPFp165H91jIFJKebB53ROw~a464fa61057e1f0274a1fa8609d1f55b

Upcoming events on Dermapharm Holding SE

2025-05-14 Q1 2025 Earnings Release
2025-06-25 Annual General Meeting
2025-08-25 Q2 2025 Earnings Release
2025-11-12 Q3 2025 Earnings Release
2026-04-14 Q4 2025 Earnings Release (Projected)
2026-05-19 Q1 2026 Earnings Release (Projected)
2026-08-31 Q2 2026 Earnings Release (Projected)
2026-11-17 Q3 2026 Earnings Release (Projected)

Past events on Dermapharm Holding SE

2025-03-14 02:30 am Q4 2024 Earnings Release
2024-11-24 German Equity Forum
2024-11-14 01:30 am Q3 2024 Earnings Release
2024-08-27 01:30 am Q2 2024 Earnings Release
2024-08-26 Q2 2024 Earnings Call
2024-06-26 Annual General Meeting
2024-05-15 01:30 am Q1 2024 Earnings Release
2024-05-14 Q1 2024 Earnings Call
2024-03-28 02:30 am Q4 2023 Earnings Release
2024-03-27 Q4 2023 Earnings Call
2023-11-15 01:30 am Q3 2023 Earnings Release
2023-11-14 Q3 2023 Earnings Call
2023-08-29 01:30 am Q2 2023 Earnings Release
2023-08-28 Q2 2023 Earnings Call
2023-06-13 Annual General Meeting
2023-05-14 Q1 2023 Earnings Release
2023-03-27 Q4 2022 Earnings Call
2023-03-27 Q4 2022 Earnings Release
2023-03-12 Berenberg EU Opportunities Conference
2022-12-04 Berenberg European Conference

Past dividends on Dermapharm Holding SE

2024-06-27 Annual 0.88 EUR
2023-06-14 Annual 1.05 EUR
2022-06-01 Annual 2.17 EUR
2021-06-23 Annual 0.88 EUR
2020-06-17 Other Dividend 0.8 EUR
2019-06-04 Other Dividend 0.77 EUR

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024 2025 2026
Net sales
Million EUR
Released
Forecast
Spread
943
944
-0.13%
1 025
1 038
-1.28%
1 135
1 125
0.91%

1 168


1 211


1 266

EBITDA
Million EUR
Released
Forecast
Spread
351
348
0.76%
360
360
-0.13%
310
299
3.82%

311


333


348

EBIT
Million EUR
Released
Forecast
Spread
298
295
1.29%
244
284
-14.16%
183
203
-9.68%

214


237


247

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
293
288
1.75%
216
274
-21.03%
106
139
-23.7%

168


191


200

Net income
Million EUR
Released
Forecast
Spread
210
204
2.81%
134
193
-30.51%
62,4
110
-43.14%

113


134


142

EPS
EUR
Released
Forecast
Spread
3,89
3,79
2.71%
2,49
3,58
-30.49%
1,16
2,04
-43.07%

2,10


2,49


2,64

Announcement Date12/04/2228/03/2328/03/24-

Quarterly results

Fiscal PeriodSeptember 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million EUR
Released
Forecast
Spread
319
289
10.42%
263
260
1.15%
582
581
0.19%



269
291
-7.53%
299
280
6.68%







295

EBITDA
Million EUR
Released
Forecast
Spread
106
91,1
16.2%
62,2
62,0
0.32%
168
164
2.44%



66,4
74,0
-10.27%
88,7
76,2
16.4%



87,3
73,0
19.59%

74,2

Net income
Million EUR
Released
Forecast
Spread
49,1
36,7
33.78%






24,8








17,3








EPS
EUR
Released
Forecast
Spread









0,46








0,32








Announcement Date15/05/2329/08/2329/08/2316/11/2328/03/2415/05/2427/08/24--

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. DMP Stock
  4. Calendar Dermapharm Holding SE